Find information on thousands of medical conditions and prescription drugs.

Dimenhydrinate

Dimenhydrinate, also known by the trade names Dramamine and Gravol, is an over-the-counter drug used to prevent motion-sickness (emesis). It is closely related to diphenhydramine HCl, or Benadryl. The differences relate to the weight-for-weight potency (50mg dimenhydrinate contains 30mg of the drug diphenhydramine), delay of action (dimenhydrinate must dissociate into diphenhydramine and its counterion in the body before it is active, therefore diphenhydramine produces effects sooner), and degree of sedation produced. more...

Home
Diseases
Medicines
A
B
C
D
Dacarbazine
Dactinomycin
Dalmane
Danazol
Dantrolene
Dapoxetine
Dapsone
Daptomycin
Daraprim
Darvocet
Darvon
Daunorubicin
Daunorubicin
Daypro
DDAVP
Deca-Durabolin
Deferoxamine
Delsym
Demeclocycline
Demeclocycline
Demerol
Demulen
Denatonium
Depakene
Depakote
Depo-Provera
Desferal
Desflurane
Desipramine
Desmopressin
Desogen
Desogestrel
Desonide
Desoxyn
Desyrel
Detrol
Dexacort
Dexamethasone
Dexamfetamine
Dexedrine
Dexpanthenol
Dextran
Dextromethorphan
Dextromoramide
Dextropropoxyphene
Dextrorphan
Diabeta
Diacerein
Diacetolol
Dial
Diamox
Diazepam
Diazoxide
Dibenzepin
Diclofenac
Diclohexal
Didanosine
Dieldrin
Diethylcarbamazine
Diethylstilbestrol
Diethyltoluamide
Differin
Diflucan
Diflunisal
Digitoxin
Digoxin
Dihydrocodeine
Dihydroergotamine
Dihydrotachysterol
Dilantin
Dilaudid
Diltahexal
Diltiazem
Dimenhydrinate
Dimercaprol
Dimetapp
Dimethyl sulfoxide
Dimethyltryptamine
Dimetridazole
Diminazene
Diovan
Dioxybenzone
Diphenhydramine
Diphenoxylate
Dipipanone
Dipivefrine
Diprivan
Diprolene
Diproteverine
Dipyridamole
Disulfiram
Disulfiram
Dizocilpine
Dobutamine
Docetaxel
Docusate sodium
Dofetilide
Dolasetron
Dolobid
Dolophine
Domperidone
Donepezil
Dopamine
Dopram
Doral
Doramectin
Doriden
Dornase alfa
Doryx
Dostinex
Doxapram
Doxazosin
Doxepin
Doxil
Doxil
Doxorubicin
Doxy
Doxycycline
Doxyhexal
Doxylamine
Drisdol
Drixoral
Dronabinol
Droperidol
Drospirenone
Duloxetine
Durabolin
Duragesic
Duraphyl
Duraquin
Dutasteride
Dv
Dyclonine
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Chemically, dimenhydrinate is a salt of two drugs: diphenhydramine(+) and 8-chlorotheophyllinate(-). Chlorotheophyllinate is a chlorinated form of the drug theophylline. The chlorination provides the necessary charge to associate with diphenhydramine as a solid. Theophylline is very closely related to caffeine and theobromine, mild central nervous system stimulants. It was thought that by combining the antiemetic effects of diphenhydramine with a stimulant, the extreme drowsiness induced by the former could be mitigated somewhat by the latter. In actuality, the sedation caused by diphenhydramine is substantially stronger than the stimulation caused by chlorotheophyllinate. Diphenhydramine, an ethanolamine-class antihistamine, is found in most OTC sleep aids and allergy preparations, such as Tylenol PM and Benadryl. It is primarily a H1-antagonist, but also possesses an antimuscarinic effect. It is used in Dramamine to produce and prevent nausea and emesis, however the development of the chemical meclizine has overtaken its usage (marketed as "Dramamine II") due to the fact that meclizine doesn't produce as much drowsiness.

Abuse

Recreational drug users sometimes take several times the recommended dose of dimenhydrinate in order to attain an intense and long-lasting state of anticholinergic delirium.

The mental effects are described by many as "dreaming while awake" involving visual and auditory hallucinations which, unlike those experienced with recreational drugs known as psychedelics, often cannot be readily distinguished from reality. Users often report a highly unpleasant side effect profile consistent with tropane glycoalkaloidal poisoning. This includes dry mouth and eyes, rapid heart beat (tachycardia), somnolence, insomnia, and extreme malaise. This is due to antagonism of muscarinic acetylcholine receptors in both the central and autonomic nervous system, inhibiting various signal transduction pathways.

In the CNS, diphenhydramine readily crosses the blood-brain barrier, exerting effects within the visual and auditory cortex, accounting for reported visual and auditory disturbances. Other CNS effects occur within the limbic system and hippocampus, causing confusion and temporary amnesia. Toxicology also manifests in the autonomic nervous system, primarily at the neuromuscular junction, resulting in ataxia and extrapyramidal side-effects, and at sympathetic post-ganglionic junctions, causing urinary retention, pupil dialation, tachycardia, and dry skin & mucous membranes. Considerable overdosage can lead to myocardial infarction, serious ventricular dysrhythmias, coma and death. Such a side-effect profile is thought to give ethanolamine-class antihistamines a relatively low abuse liability.

Read more at Wikipedia.org


[List your site here Free!]


Lorazepam vs. Dimenhydrinate in Treating Vertigo
From American Family Physician, 4/1/01 by Richard Sadovsky

Vertigo is the impression of motion of oneself or one's surroundings. The management of acute vertigo in the emergency department includes therapy with anticholinergics, antihistamines, benzodiazepines, calcium channel blockers, neuroleptics or glucocorticoids, and maneuvers for benign postural vertigo. Marill and associates compared the efficacy of a benzodiazepine with that of an antihistamine in the treatment of vertigo.

Antihistamines are thought to work as vestibular suppressants, whereas benzodiazepines potentiate the inhibitory g-aminobutyric acid, centrally inhibiting vestibular responses. Parenteral formulations were used because of better tolerance in patients with nausea and vomiting. Intravenous dimenhydrinate (in a dosage of 50 mg) or lorazepam (in a dosage of 2 mg) were given in a random and blinded manner to 74 consenting patients presenting with acute vertigo. There was no placebo group because some patients in this group would probably not improve without treatment, and withholding treatment would be unethical. At one and two hours after treatment, participants recorded the level of vertigo they experienced in various positions as well as any feeling of nausea or drowsiness. Vertigo during ambulation was noted before treatment and at one and two hours after treatment.

The primary end point, the patient's sensation of vertigo with ambulation, as well as the secondary measurements of efficacy, were found to have improved more after dimenhydrinate treatment. Patients in both groups experienced increased drowsiness at one hour after treatment, but after two hours drowsiness returned to baseline levels in the dimenhydrinate group. Patients in the lorazepam group experienced significantly more drowsiness. Other serious side effects were rare.

The authors conclude that dimenhydrinate treatment of patients with acute vertigo provides a greater decrease in the primary end point, vertigo with ambulation, as well as other secondary end points, than lorazepam. However, the differences in improvement are small. Sedation was greater after lorazepam treatment, which delayed discharge of otherwise symptomatically improved patients. Therefore, dimenhydrinate appears to be the preferred intravenous agent for relief of vertigo in the emergency department setting.

COPYRIGHT 2001 American Academy of Family Physicians
COPYRIGHT 2001 Gale Group

Return to Dimenhydrinate
Home Contact Resources Exchange Links ebay